These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 231162)

  • 1. The effects of partial opiate agonists on plasma prolactin and growth hormone levels in the rat.
    Lein EL; Morrison A; Dvonch W
    Life Sci; 1979 Nov; 25(20):1709-15. PubMed ID: 231162
    [No Abstract]   [Full Text] [Related]  

  • 2. A steric theory of opioid agonists, antagonists, agonist-antagonists, and partial agonists.
    Martin WR
    NIDA Res Monogr; 1984 Mar; 49():16-23. PubMed ID: 6090916
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocrine actions of opioids.
    Pfeiffer A; Herz A
    Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta opioid receptor selective alkaloid agonists and antagonists.
    Woods JH; DeCosta B; Jacobson AE; Rice KC; Medzihradsky F; Smith CB; Comer S; France CP; Winger G
    NIDA Res Monogr; 1989; 95():300-1. PubMed ID: 2561836
    [No Abstract]   [Full Text] [Related]  

  • 5. Affinities of opiate agonists and antagonists for the enkephalin receptors of rat brain.
    Wong DT; Horng JS
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):749-52. PubMed ID: 193169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity of opioid agonists and antagonists for the various opioid receptor types.
    Takemori AE; Portoghese PS
    Psychopharmacol Bull; 1985; 21(3):464-5. PubMed ID: 2994158
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo antagonism of analgesia and respiratory depression induced by proposed mu and kappa opiate agonists [proceedings].
    Metcalf G; Rees JM; Ward SJ
    Br J Pharmacol; 1979 Jul; 66(3):473P-474P. PubMed ID: 230881
    [No Abstract]   [Full Text] [Related]  

  • 10. Buprenorphine effects on plasma luteinizing hormone and prolactin in male heroin addicts.
    Mendelson JH; Ellingboe J; Mello NK; Kuehnle J
    J Pharmacol Exp Ther; 1982 Feb; 220(2):252-5. PubMed ID: 7057390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple in vivo tests that differentiate prototype agonists at opiate receptors.
    Cowan A
    Life Sci; 1981 Apr; 28(14):1559-70. PubMed ID: 6264252
    [No Abstract]   [Full Text] [Related]  

  • 12. One- and two-receptor models of opioid drug action.
    Gero A
    Life Sci; 1985 Mar; 36(11):1021-4. PubMed ID: 2983162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of opiate antagonists on serotonin turnover and on luteinizing hormone and prolactin secretion in estrogen- or morphine-treated rats.
    Johnson MD; Crowley WR
    Neuroendocrinology; 1984 Apr; 38(4):322-7. PubMed ID: 6328344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of opiate receptor agonists and antagonists on the resistance of animals to hypoxic hypoxia].
    Zakusov VV; Iasnetsov VV; Ostrovskaia RU; Chukaev VV; Motin VG
    Biull Eksp Biol Med; 1984 Dec; 98(12):680-2. PubMed ID: 6095953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of new compounds for opioid activity (1983).
    Woods JH; Winger GD; Medzihradsky F; Smith CB; Katz JL
    NIDA Res Monogr; 1984 Mar; 49():361-7. PubMed ID: 6090918
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of norepinephrine release from rat cortex slices by opioids: differences among agonists in sensitivities to antagonists suggest receptor heterogeneity.
    Kim KW; Cox BM
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1153-60. PubMed ID: 8263776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glycine and GABA receptor binding by several opiate agonists and antagonists.
    Goldinger A; Müller WE; Wollert U
    Gen Pharmacol; 1981; 12(6):477-9. PubMed ID: 6273257
    [No Abstract]   [Full Text] [Related]  

  • 20. A proposed mode of action for narcotic agonists and antagonists.
    Cho TM; Law PY; Loh HH
    Adv Biochem Psychopharmacol; 1979; 20():69-101. PubMed ID: 224664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.